Search

Author/Creator Benesh, Janet

1. Effect of Levodopa‐carbidopa Intestinal Gel on Non‐motor Symptoms in Patients with Advanced Parkinson's Disease. Issue 6 (20th September 2017)

Authors:
Standaert, David G.; Rodriguez, Ramon L.; Slevin, John T.; Lobatz, Michael; Eaton, Susan; Chatamra, Krai; Facheris, Maurizio F.; Hall, Coleen; Sail, Kavita; Jalundhwala, Yash J.; Benesh, Janet
Journal:
Movement disorders clinical practice
Issue:
Volume 4:Issue 6(2017)
Page Start:
829
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Effects of levodopa-carbidopa intestinal gel on non-motor symptoms and safety of outpatient titration: A new phase 3 study in patients with advanced Parkinson's disease. (January 2016)

Authors:
Standaert, David; Slevin, John; Hall, Coleen; Dubow, Jordan; Eaton, Susan; Chatamra, Krai; Benesh, Janet
Journal:
Parkinsonism & related disorders
Issue:
Volume 22(2016)Supplement 2
Page Start:
e17
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Long‐Term PEG‐J Tube Safety in Patients With Advanced Parkinson's Disease. Issue 3 (March 2016)

Authors:
Epstein, Michael; Johnson, David A; Hawes, Robert; Schmulewitz, Nathan; Vanagunas, Arvydas D; Gossen, Roderich E; Robieson, Weining Z; Eaton, Susan; Dubow, Jordan; Chatamra, Krai; Benesh, Janet
Journal:
Clinical and translational gastroenterology
Issue:
Volume 7:Issue 3(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Long‐term safety and efficacy of levodopa‐carbidopa intestinal gel in advanced Parkinson's disease. Issue 6 (23rd March 2018)

Authors:
Fernandez, Hubert H.; Boyd, James T.; Fung, Victor S. C.; Lew, Mark F.; Rodriguez, Ramon L.; Slevin, John T.; Standaert, David G.; Zadikoff, Cindy; Vanagunas, Arvydas D.; Chatamra, Krai; Eaton, Susan; Facheris, Maurizio F.; Hall, Coleen; Robieson, Weining Z.; Benesh, Janet; Espay, Alberto J.
Journal:
Movement disorders
Issue:
Volume 33:Issue 6(2018)
Page Start:
928
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Safety and efficacy of levodopa-carbidopa intestinal gel: results from an open-label extension study in Japanese, Korean and Taiwanese patients with advanced Parkinson's disease. (23rd February 2018)

Authors:
Murata, Miho; Mihara, Masahito; Hasegawa, Kazuko; Jeon, Beomseok; Tsai, Chon-Haw; Nishikawa, Noriko; Oeda, Tomoko; Yokoyama, Masayuki; Robieson, Weining Z.; Chatamra, Krai; Facheris, Maurizio F.; Benesh, Janet
Journal:
Therapeutic advances in neurological disorders
Issue:
Volume 11(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson's Disease Receiving ≥2000 mg Daily Dose of Levodopa. (13th February 2020)

Authors:
Zadikoff, Cindy; Poewe, Werner; Boyd, James T.; Bergmann, Lars; Ijacu, Horia; Kukreja, Pavnit; Robieson, Weining Z.; Benesh, Janet; Antonini, Angelo
Other Names:
Pisani Antonio Academic Editor.
Journal:
Parkinson's disease
Issue:
Volume 2020(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Updated long-term safety from ongoing phase 3 trials of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease. (January 2016)

Authors:
Rodriguez, Ramon; Schmulewitz, Nathan; Stein, David; Robieson, Weining; Hall, Coleen; Eaton, Susan; Chatamra, Krai; Benesh, Janet; Espay, Alberto
Journal:
Parkinsonism & related disorders
Issue:
Volume 22(2016)Supplement 2
Page Start:
e84
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗